Patent: 9,447,401
✉ Email this page to a colleague
Summary for Patent: 9,447,401
| Title: | PH20 polypeptide variants, formulations and uses thereof |
| Abstract: | Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof. |
| Inventor(s): | Wei; Ge (San Diego, CA), Shepard; H. Michael (San Diego, CA), Zhao; Qiping (San Diego, CA), Connor; Robert James (Oceanside, CA) |
| Assignee: | Halozyme, Inc. (San Diego, CA) |
| Application Number: | 13/694,731 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,447,401
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 10/28/1982 | ⤷ Try a Trial | 2031-12-30 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 12/29/2015 | ⤷ Try a Trial | 2031-12-30 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 08/06/1998 | ⤷ Try a Trial | 2031-12-30 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 03/31/1994 | ⤷ Try a Trial | 2031-12-30 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 05/25/2018 | ⤷ Try a Trial | 2031-12-30 |
| Sanofi-aventis U.s. Llc | APIDRA | insulin glulisine | Injection | 021629 | 04/16/2004 | ⤷ Try a Trial | 2031-12-30 |
| Sanofi-aventis U.s. Llc | APIDRA | insulin glulisine | Injection | 021629 | 12/20/2005 | ⤷ Try a Trial | 2031-12-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
